Austin Carter
Overview
Explore the profile of Austin Carter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
2460
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Witte J, Ayim E, Sams C, Service J, Kant C, Bambalas L, et al.
J Org Chem
. 2024 Jun;
89(13):9569-9585.
PMID: 38916048
Darunavir is a potent HIV protease inhibitor that has been established as an effective tool in the fight against the progression of HIV/AIDS in the global community. The successful application...
2.
Shattock A, Johnson H, Sim S, Carter A, Lambach P, Hutubessy R, et al.
Lancet
. 2024 May;
403(10441):2307-2316.
PMID: 38705159
Background: WHO, as requested by its member states, launched the Expanded Programme on Immunization (EPI) in 1974 to make life-saving vaccines available to all globally. To mark the 50-year anniversary...
3.
Carter A, Msemburi W, Sim S, Gaythorpe K, Lambach P, Lindstrand A, et al.
Vaccine
. 2023 Aug;
42 Suppl 1:S28-S37.
PMID: 37537094
Background: The Immunization Agenda 2030 (IA2030) Impact Goal 1.1. aims to reduce the number of future deaths averted through immunization in the next decade. To estimate the potential impact of...
4.
Bollyky T, Castro E, Aravkin A, Bhangdia K, Dalos J, Hulland E, et al.
Lancet
. 2023 Mar;
401(10385):1341-1360.
PMID: 36966780
Background: The USA struggled in responding to the COVID-19 pandemic, but not all states struggled equally. Identifying the factors associated with cross-state variation in infection and mortality rates could help...
5.
Wulf Hanson S, Abbafati C, Aerts J, Al-Aly Z, Ashbaugh C, Ballouz T, et al.
JAMA
. 2022 Oct;
328(16):1604-1615.
PMID: 36215063
Importance: Some individuals experience persistent symptoms after initial symptomatic SARS-CoV-2 infection (often referred to as Long COVID). Objective: To estimate the proportion of males and females with COVID-19, younger or...
6.
Wulf Hanson S, Abbafati C, Aerts J, Al-Aly Z, Ashbaugh C, Ballouz T, et al.
medRxiv
. 2022 Jun;
PMID: 35664995
Importance: While much of the attention on the COVID-19 pandemic was directed at the daily counts of cases and those with serious disease overwhelming health services, increasingly, reports have appeared...
7.
Henry J, Carter A, Smith D
Malar J
. 2022 Apr;
21(1):117.
PMID: 35392918
Background: Accurate estimation of the burden of Plasmodium falciparum is essential for strategic planning for control and elimination. Due in part to the extreme heterogeneity in malaria exposure, immunity, other...
8.
Friedman J, Liu P, Troeger C, Carter A, Reiner Jr R, Barber R, et al.
Nat Commun
. 2021 May;
12(1):2609.
PMID: 33972512
Forecasts and alternative scenarios of COVID-19 mortality have been critical inputs for pandemic response efforts, and decision-makers need information about predictive performance. We screen n = 386 public COVID-19 forecasting...
9.
Carter A, Akseer N, Ho K, Rothschild O, Bose N, Binagwaho A, et al.
BMJ Glob Health
. 2020 Dec;
5(12).
PMID: 33272938
This paper introduces a framework for conducting and disseminating mixed methods research on positive outlier countries that successfully improved their health outcomes and systems. We provide guidance on identifying exemplar...
10.
Friedman J, Liu P, Troeger C, Carter A, Reiner R, Barber R, et al.
medRxiv
. 2020 Nov;
PMID: 33236023
Forecasts and alternative scenarios of COVID-19 mortality have been critical inputs into a range of policies and decision-makers need information about predictive performance. We identified n=386 public COVID-19 forecasting models...